Search


Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

These concepts are used in modeling (medicinal product form) concepts in the International Release; they are not allowed to model (clinical drug) concepts in the International Release.

Modeling

...

Pharmaceutical dose form grouper concepts based on intended site shall be modeled using the proximal primitive modeling pattern. 

Parent concept

736542009 |Pharmaceutical dose form (dose form)

Semantic tag

(dose form)

Definition status
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|

Defined

Attribute:

Has dose form intended site

Range: << 736479009 |Dose form intended site (intended site)

Cardinality: 0..*

NOTE:
    • While the allowed range is broader, the grouper concepts based on dose form intended site should have one or more |Has dose form intended site| attributes.

Naming

...

FSN

Use the following pattern for the FSN; align naming

and case sensitivity with

and case sensitivity with the FSN for the concept that is selected as the attribute value

, excluding the semantic tag

. For multiple intended sites, the intended sites must be in alphabetical order and separated by the word

“or”

“and”.

  • <Dose form intended site FSN> dose form (dose form)
  • <Dose form intended site FSN>
 or
  • and <Dose form intended site FSN> dose form (dose form)

Example:

Cutaneous

For example,

      • Conventional release cutaneous dose form (dose form)
Oral
      • Conventional release oral dose form (dose form)
Parenteral
      • Conventional release parenteral dose form (dose form)
Ocular or otic dose form
      • Conventional release ear and eye and nose drops (dose form)
Nasal or ocular or otic dose form
      • Conventional release ear and eye drops (dose form)

Preferred Term

Use the following pattern for the PT; align naming and case sensitivity with the PT for the concept that is selected as the attribute value. For multiple intended sites, the intended sites must be in alphabetical order and separated by the word

“or”

“and”.

  • <Dose form intended site PT> dose form (dose form)
  • <Dose form intended site PT>
 or
  • and <Dose form intended site PT> dose form (dose form)
Example:

For example,

      • Cutaneous dose form
      • Oral dose form
      • Parenteral dose form
  • Ocular or otic dose form
  • Nasal or ocular or otic dose form
        • Ear and eye and nose drops 
        • Ear and eye drops

    Synonyms

    Synonyms are not allowed unless explicitly identified as an exception in the Editorial Guidelines.

    Text definitionsOptional

    ...

    Exemplar

    The following illustrates the stated the stated view for grouper concept 740596000 |Cutaneous dose form (dose form)|:

    The following illustrates the inferred view for grouper concept 740596000 |Cutaneous dose form (dose form)|:

    Image Removed

    The following illustrates the stated view for grouper concept 765166009 |Ocular or otic dose form (dose form)|:

    Image Removed

    The following illustrates the inferred view for grouper concept 765166009 |Ocular or otic dose form (dose form)|:

    Image Removed